Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability

Area of Science:

• Hepatology
• Clinical Prognostics
• Medical Statistics

Background:

• Primary biliary cirrhosis (PBC) is a chronic liver disease.
• Accurate survival prediction is crucial for managing PBC patients.
• The Mayo model is a widely used prognostic tool for PBC.

Purpose of the Study:

• To validate the generalizability of the Mayo model for predicting survival in primary biliary cirrhosis (PBC) patients.
• To assess the model's accuracy across different patient cohorts and disease severities.
• To determine if adding histologic staging improves the model's predictive power.

Main Methods:

• The Mayo model was applied to independent patient databases from New England Medical Center Hospitals and Scott and White Clinic.
• Model performance was evaluated for accuracy in predicting patient survival.
• Statistical analyses were conducted to assess the impact of adding histologic staging to the model.

Main Results:

• The Mayo model demonstrated accurate survival prediction in external patient cohorts.
• The model's accuracy was confirmed even in patients with very advanced disease (less than 33% 12-month survival chance).
• Inclusion of histologic stage did not significantly enhance the model's predictive capability (p > 0.10).

Conclusions:

• The Mayo model is a generalizable and accurate tool for predicting survival in primary biliary cirrhosis patients.
• The model's utility extends to patients with advanced disease stages.
• The Mayo model serves as a practical instrument for clinical management and treatment decisions in PBC.